PIDILITIND
NIFTY100

Pidilite Industries Ltd.

Chemicals · NSE

₹1,476.00
1Y-1.1%
P/E61.0
Fwd P/E49.3
ROE+23.5%
Margin+16.8%
D/E3.78
Div Yld+0.7%
Quality Score76/100
Analyst consensus:Constructive· 19 analysts

52-week range

₹1,259₹1,575

From 52w high

-6.3%

RSI (14)

67.7

vs SMA 50 / 200

50 · 200

Pidilite Industries (PIDILITIND) is a consumer and industrial adhesives company in the Chemicals sector, trading at ₹1,468.50 as of 11 May 2026. It holds the top quality score (66) and ROE rank (23.52%) among 6 tracked peers, while the trailing PE of 61.03 is the highest in the peer group. Over 12 months the share price has returned -0.61%, even as Q4 FY26 net profit rose 37% YoY to ₹579 crore.

Pros
  • Highest quality score in the 6-stock Chemicals peer group (66 vs next-best 57 for SOLARINDS), reflecting a composite of profitability, consistency, and capital efficiency.
  • ROE of 23.52% ranks 1st among peers with available data (next-best: Coromandel at 15.59%), and FCF was positive in 4 of the available fiscal years with a consistency score of 81.
  • 5-year earnings growth of 37% CAGR and 5-year revenue growth of 14.1% demonstrate sustained compounding through varied macro cycles.
  • Price is 0.4% above the 200-DMA (₹1,462.39) and 6.1% above the 50-DMA (₹1,383.38), with RSI at 65.7 — the stock sits close to long-term trend support after a 52-week drawdown of only -6.76%.
Cons
  • Trailing PE of 61.03 is the highest in the peer group, representing approximately a 78% premium to the approximate peer median PE of ~34; any earnings deceleration could compress this multiple materially.
  • Debt-to-equity of 3.776 is elevated for a consumer-facing chemicals business; while the debt trend is classified as flat, this level limits balance-sheet flexibility in a rising-rate or demand-shock environment.
  • Twelve-month price change of -0.61% means the share price has returned nothing nominally over the past year, underperforming even risk-free alternatives over that window.
  • ROE above 15% was achieved in 4 of the available fiscal years (not all 5), and FCF was positive in 4 of those years, indicating occasional dips in capital returns and cash generation that prevent a perfect consistency record.
Recent context
  • ·Q4 FY26 results (reported 7–8 May 2026) showed net profit of ₹579 crore, up 37% YoY, with double-digit revenue and volume growth; management cited price hikes to offset raw-material inflation.
  • ·The board announced a bonus share issue alongside FY26 full-year results, a corporate action that historically affects near-term price discovery and share count.
  • ·Mean analyst rating of 2.21 across 19 analysts (1–5 scale, lower = more constructive); coverage involves 19 analysts, suggesting moderate institutional research attention for a mid-to-large Chemicals name.
Questions to ask yourself
  • ?Does the 37% earnings CAGR over 5 years reflect a structural shift in adhesive penetration in India, or is it amplified by a low-base period that may normalise going forward?
  • ?At a trailing PE of 61 — roughly 78% above the peer median — what rate of earnings growth would be needed to bring the valuation in line with historical multiples, and how does the current growth trajectory compare to that threshold?
  • ?The debt-to-equity of 3.776 is flat-trending but elevated; how does total debt composition (short-term vs long-term) and interest coverage compare to prior years, and what events could pressure coverage ratios?
  • ?The bonus share issue announced alongside Q4 results is a non-cash corporate action; historically, how has Pidilite's share price behaved in the 3–6 month window following previous bonus issuances?

PE

61.0

Forward PE

49.3

ROE

+23.5%

Profit margin

+16.8%

D/E

3.78

Dividend yield

+0.7%

Quality score

66/100

ROE 5y above 15%

4/5 yrs

FCF 5y positive

4/5 yrs

Analyst consensus2.21 · 19 analysts(1–5 scale, lower = more constructive)

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 11 May 2026.